|
at 08:20 |
|
|
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the availability of Evercodetm BCR and the expansion of its existing Evercodetm TCR product line. The new BCR solution and updates to...
|
|
at 08:20 |
|
|
For organ transplant recipients, life post-transplant involves a delicate balance between invasive monitoring and immunosuppression to reduce the risk of rejection, both of which may carry complications. Now, a simple, urine-based assay that detects...
|
|
at 08:17 |
|
|
Analysts, investors, and the media are invited to a presentation of RaySearch's interim report for the first quarter of 2024 on May 17, 2024, at 10.00 am CEST. The report will be published on May 17, 2024, at 07.45 am and will be available together...
|
|
at 08:17 |
|
|
One of the largest veterans nonprofits shares suicide risk reduction strategies at one of the leading conferences on suicide prevention this week. Wounded Warrior Project® (WWP) will offer insights applicable to veterans and others at risk....
|
|
at 08:15 |
|
|
Pulse Biosciences, Inc. ("Pulse" or the "Company"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced that the Company's Board of Directors has set the record date for the...
|
|
at 08:15 |
|
|
Reprieve Cardiovascular, Inc. (?Reprieve'), a development stage company focused on pioneering an intelligent approach to acute decompensated heart failure (ADHF) treatment, today highlighted the publication of TREAT-AHF study results in JACC: Heart...
|
|
|
